Latest 8-K filings

Cadrenal Therapeutics has launched a formal strategic process to explore options for maximizing shareholder value, including potential licensing, partnerships, or sale of assets.

Angel Oak Mortgage REIT, Inc. has adopted Fifth Amended and Restated Bylaws to enhance procedures for shareholder meetings, director nominations, and special meeting requests.

Pulse Biosciences announced it has successfully enrolled 164 evaluable patients in its NANOPULSE-AF clinical study for the nPulse Cardiac Catheter System, achieving its target ahead of schedule.

Coffee Holding Co., Inc. announced its Board of Directors has approved a $2.5 million share repurchase program, signaling confidence in its current stock valuation.

Alkami Technology, Inc. reports the resignation of its Chief Accounting Officer, Prerna Sachdeva, effective November 2, 2026, with CFO Cassandra Hudson stepping in as interim principal accounting officer.

BioNexus Gene Lab Corp. has entered into a strategic collaboration and licensing agreement with Ruanyun Edai Technology Inc. for exclusive rights to the CogniAI document-intelligence platform in Malaysia.

Modine Manufacturing Company has filed an amendment to its Form 8-K to include unaudited pro forma financial information following the completion of its previously announced spin-off of the Performance Technologies business and its combination with Gentherm.

Ultragenyx Pharmaceutical Inc. has entered into an agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for $210 million, bolstering its financial resources.

Envoy Medical, Inc. has entered into a Dismissal Agreement to resolve litigation with Atlas Merchant Capital SPAC Fund I LP concerning share redemption rights.

Onfolio Holdings has received an extension until November 23, 2026, to regain compliance with Nasdaq's minimum stockholders equity requirement.

BioCardia announced the presentation of its CardiAMP HF II trial design at the Heart Failure Society of America Annual Scientific Meeting, signaling progress in its cardiovascular therapeutic development.

Neogen Corporation's 2026 Annual Meeting saw overwhelming shareholder approval for director elections, executive compensation, and incentive plans, alongside ratification of auditors.

Bitmine Immersion Technologies anticipates the largest crypto bull market to date, driven by institutional adoption, tokenization, and a generational wealth transfer, with the company strategically positioned for significant ETH appreciation.

AIB Data Centers announced a 12-year, 50 MW agreement with Nebius for its CLT1 campus, supported by customer prepayments and project financing, avoiding immediate corporate equity needs.

Ellington Financial Inc. announced its Board of Directors has declared a monthly dividend of $0.13 per share of common stock, payable on November 30, 2026.

Ellington Credit Company announced a monthly common distribution of $0.08 per share, payable on November 30, 2026.

TaoWeave announced its portfolio company, Manako Labs, has successfully launched its Physical AI platform with Avia Thvenin-Ducrot across 124 unmanned fuel stations in France.

Launch Two Acquisition Corp. has further postponed its extraordinary general meeting to October 8, 2026, to approve an extension for its business combination deadline.

Cero Therapeutics Holdings, Inc. has entered into a Stock Purchase Agreement to sell all outstanding capital stock of its wholly-owned operating subsidiary, CERo Therapeutics, Inc., to SRX Global Inc.

Beeline Holdings, Inc. announced it will host a stakeholder update call on November 12, 2026, to review its third-quarter 2026 financial results and provide updates on ongoing initiatives.

BILI Social International, Inc. has changed its transfer agent from Equiniti Trust Company LLC to VStock Transfer, LLC, effective October 2, 2026.

Charlton Aria Acquisition Corporation and KQC Quantum, Inc. have signed a definitive agreement for a business combination, aiming to take the Korean quantum computing and security firm public on Nasdaq.

OpenWorld, Inc. has announced a non-binding term sheet for a proposed up to $130 million intellectual property-backed financing with Beyond Limits, Inc. (BeyondAI), utilizing tokenization.

The Mexico Fund, Inc. (MXF) released its September 30, 2026, monthly summary report, detailing net assets of $329.90 million and a NAV per share of $22.88, while the closing price was $20.39.

FuelCell Energy announces the departure of its CFO, Michael S. Bishop, who will transition to Senior Advisor, and appoints Matthew Latino as the new Executive Vice President, Chief Financial Officer.

Jasper Therapeutics has commenced an offer to purchase all outstanding warrants issued in its September 2025 public offering for $0.324 cash per warrant.

SRX Global Inc. has entered into a Stock Purchase Agreement to acquire CERo Therapeutics, Inc., which includes forgiving a substantial promissory note and assuming certain liabilities.

WillScot Holdings Corporation announced the election of Donald W. Slager to its Board of Directors, effective October 7, 2026, as part of its ongoing board refreshment efforts.

Azenta, Inc. is implementing a restructuring plan involving workforce reductions and lab closures, expecting to incur $11.0M-$13.0M in pre-tax charges.

LogicMark, Inc. announced that its stockholders approved the Agreement and Plan of Merger at a special meeting held on October 5, 2026.